Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
AGAP1 intronic transcript 1 (non-protein coding) (AGAP1-IT1)
- Target
- AGAP1-IT1
- Molecular classification
- Long noncoding RNA (lncRNA), Intronic transcript, Other (as it does not fall into conventional protein-based molecular families)
01
Overview
AGAP1 intronic transcript 1 (AGAP1-IT1) is a long noncoding RNA (lncRNA) located within an intron of the AGAP1 gene. It does not appear to encode a functional protein or micropeptide (as indicated by a negative CNIT score). AGAP1-IT1 is upregulated in osteosarcoma tissue compared to normal bone and is predominantly localized to the cytosol. Its specific cellular and molecular interactions remain largely uncharacterized, and there is little evidence to suggest a direct role in therapeutic intervention or as a receptor, enzyme, or transporter. The broader importance of intronic lncRNAs in cancer and cell regulation is recognized, but AGAP1-IT1's unique function requires further study.
- Other names
- AGAP1 intronic transcript 1AGAP1-IT1AGAP1-IT1 (non-protein coding)
02
Mechanism of action
Not applicable, as there are currently no drugs or interventions targeting AGAP1-IT1
03
Biological functions
Possible regulatory role as lncRNA (specific functions of AGAP1-IT1 remain undetermined)May be involved in gene expression regulation in cancer-related contexts, such as osteosarcoma, typically through RNA-RNA or RNA-protein interactions
04
Disease associations
Cancer (differentially upregulated in osteosarcoma versus normal tissue; potential association with cancer biology)
05
Safety considerations
None reported or identified (lncRNAs as a class may raise delivery and off-target concerns if targeted, but not specific to AGAP1-IT1)
06
Interacting drugs
None known
07
Biomarkers
AGAP1-IT1 may serve as a candidate biomarker for osteosarcoma, due to its upregulation in tumor tissue compared to normal tissue, but this is based on preliminary expression studies only
Beyond the preview
Go deeper on AGAP1 intronic transcript 1 (non-protein coding) (AGAP1-IT1).
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow the clinical studies evaluating therapies directed at this target.
- Trial design
- Status
- Readouts
Competitive landscape
Full profile accessCompare approaches across drug candidates, modalities, and indications.
- Programs
- Modalities
- Indications
Literature & evidence
Full profile accessInvestigate the research and source evidence behind target biology and development.
- Publications
- Sources
- Analysis
Patents
Full profile accessExplore patent activity around therapies and technologies addressing this target.
- Patents
- Assignees
- Technologies
Research & analysis
Full profile accessConnect target biology, drug development, and emerging evidence in your research.
- Biology
- Development news
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on AGAP1 intronic transcript 1 (non-protein coding) (AGAP1-IT1).